Introduction
The ability to induce specific ectopic expression of a transgene, while not directly affecting expression of endogenous genes, has a wide range of important applications. These include basic research aimed at identifying the function of genes in cells or animals (1), treatment of diseases through targeted gene therapy (2) , and the biotechnological production of useful biomolecules (3) . Inducible gene expression systems need to fulfill a variety of criteria, including very low basal expression; highly specific direct induction of only the inducible gene; dose-dependent response to the inducing reagent; and consistent levels of induction regardless of metabolic state or physiological context. Several inducible promoter systems have been developed, including tetrac ycline-reg u latable promoters, promoters activated by rapamycin-induced heterodimerization of FKB12 and FRB derivatives, and hormone-sensitive promoters such as those based on the progesterone antagonist mifepristone and the anti-estrogen Tamoxifen (reviewed in Reference 4) .
One of the most promising inducible gene expression systems uses the insect steroid hormone ecdysone. The ecdysone receptor (EcR) forms a heterodimer with ultraspiracle (USP), the insect ortholog of the vertebrate retinoid X receptor (RXR). In the absence of ligand, the EcR/USP complex binds to its recognition element in the promoter of EcR-responsive genes and suppresses their transcription. Upon binding of ecdysone, conformational changes in the EcR convert the complex into a transcriptional activator (5) . Insect EcR can functionally heterodimerize with vertebrate RXR. Potent inducible gene expression systems for mammalian cells have been developed using these components. A two-hybrid format (RheoSwitch), based on a Gal4-DNA binding domain fused to the EcR and a VP16-activation domain fused to the RXR, exhibits very low basal promoter activity and up to 10,000-fold induction in various mammalian cell types (6, 7) . Furthermore, it is responsive to synthetic non-steroidal ecdysone agonists such as the diacylhydrazine RSL1 (7, 8) .
Density-dependent inhibition of cell growth is a property of many types of non-transformed cells cultured in vitro, while loss of contact inhibition is a hallmark of malignant tumor cells (reviewed in Reference 9). Contact inhibition is caused by cell cycle arrest (10) . The molecular basis for contactmediated growth control is poorly understood, but could be highly relevant for the therapeutic targeting of cancer cells. In addition to cell contact, quiescence can also be induced by serum deprivation. With these observations in mind, we set out to determine the utility of the RheoSwitch system for inducing expression of genes in contact-inhibited cells and in cells in serum deprivationinduced quiescence.
Materials and methods

Cell culture
The fibroblast RheoSwitch Cell Line NIH3T3-47 (New England Biolabs, Frankfurt, Germany) was cultivated in DMEM supplemented with 10% donor calf serum (DCS). NMuMG breast epithelial cells (11) were cultured in DMEM supplemented with 10% fetal calf serum (FCS) and 10 µg/ mL insulin. For contact inhibition experiments, the cells were seeded sparsely (2.5 × 10 3 cells/cm 2 ) or densely (1 × 10 5 cells/cm 2 ) and cultivated for 56 h. For serum deprivation experiments, cells were cultivated in medium containing 0.3% serum for 48 h.
BrdU immunofluorescence
NIH 3T3 and NMuMG cell were pulsed with 10 µM BrdU (Roche Diagnostics, Mannheim, Germany) for 3 h and 2 h, respectively. Cells were subsequently fixed with 4% paraformaldehyde then permeabilized with 1% NP40/PBS. After treatment with DNase (Fermentas, St. Leon-Rot, Germany) and blocking with 10% DCS in PBS, BrdU incorporation was detected using a monoclonal rat anti-BrdU antibody [BU1/75 (ICR1), Abcam, Cambridge, UK] and an anti-rat Alexa Fluor 546 secondary antibody (Invitrogen/Molecular Probes, Inc., Eugene, OR, USA). Nuclei were stained with 10 µg/mL DAPI (SigmaAldrich, Taufkirchen, Germany). Samples were mounted with Mowiol 4-88 (Roth, Karlsruhe, Germany).
Plasmid constructs
The pNEBR-R1 regulator plasmid encoding the R heoReceptor-1 and RheoActivator protein, and the pNEBR-X1-Hygro plasmid of the RheoSwitch Cell cycle quiescence can suppress transcription from an ecdysone receptor-based inducible promoter in mammalian cells Inducible gene expression is a powerful tool for basic research, gene therapy and biotechnology, whose utility depends in part on consistent levels of induction regardless of metabolic status or physiological context. Here we examined the inducibility of the ecdysone receptor-based RheoSwitch mammalian inducible expression system in proliferating cells and in cell cycle-arrested cells. We found that both contact inhibition and growth arrest subsequent to serum deprivation dramatically reduced the levels of induction of reporter genes that could be achieved in 3T3 fibroblasts but in not NMuMG mammary epithelial cells. These data have implications for the use of the RheoSwitch system in inducible gene expression applications.
Vol. 46 | No. 6 | 2009
Short Technical Reports inducible system were purchased from New England Biolabs (Ipswich, MA, USA). The firef ly (Photinus pyralis) luciferase gene from the pGL3-BasicVector (Promega, Mannheim, Germany) was inserted into the pNEBR-X1 plasmid to create the firef ly-pNEBR-X1-Hygro construct. The full-length Pip92 cDNA was also cloned into the pNEBR-X1-Hygro vector to create the Pip92pNEBR-X1-Hygro plasmid. The Ubi-Renilla construct (pRL-CMV) was provided by Olivier Kassel (Forschungszentrum, Karlsruhe, Germany) (12) . Establishment of RheoReceptor/ RheoActivator expressing and Pip92-inducible cell lines The NIH3T3-47 cell line stably transfected with the pNEBR-R1 construct was transfected with the pNEBR-X1-Pip92 construct, and stable clones were selected with 700 µg/mL hygromycin. Single colonies were picked, re-seeded and expanded. NMuMG cells were transfected with the pNEBR-R1 plasmid and stable clones were selected using 1 mg/ mL G418. Inducible clones were selected using luciferase assays as described above.
These clones were subsequently transfected with the Pip92pNEBR-X1-Hygro construct. Stable clones were selected using 700 µg/mL hygromycin. Gates were set over the sub G1, the G0/ G1, S, and G2/M peaks, and then the percentages of cells in different cell cycle phases were calculated.
Results and discussion
To determine the utilit y of the R heoSwitch system for inducing expression of genes in contact-inhibited To determine R SL1-mediated induction of Pip92 expression with and without contact inhibition, three independent clones of 3T3-Pip92 cells were seeded at densities of 100,000 cells/ cm 2 (dense) or 2,500 cells/cm 2 (sparse). After 56 h cultivation, the dense cells were contact-inhibited while the sparse cells continued to proliferate as evidenced by BrdU incorporation and cell-cycle profile analysis (Figure 1, A and B) . The cells were then treated with RSL1 ligand for 6 h, harvested, and analyzed for Pip92 expression by Western blotting. For all three tested clones, contact inhibition strongly suppressed RSL1-induced Pip92 expression ( Figure 1C) . When the cells were serum-deprived to drive them into quiescence, RSL1-induced Pip92 . Using a luciferase reporter construct, we found that contact inhibition suppressed the maximal level of induction that could be achieved with saturating RSL1 ligand concentrations by ∼5-fold (Figure 2A) . Together, these data indicate that in NIH3T3 cells, cell cycle arrest induced by either contact inhibition or serum deprivation strongly attenuates the ability of RSL1 to induce gene expression via the RheoSwitch system.
To determine whether the loss of RSL1-induced gene expression in cell cycle-arrested 3T3 cells might be caused by reduced levels of RheoSwitch components, we performed quantitative realtime PCR to determine levels of RA and RR transcripts under the different conditions employed. As shown in Figure 2B , RA and RR transcript levels remained constant regardless of whether the cells were grown under contact-inhibited or serum-deprived conditions. R R protein levels as evidenced by Western blotting with anti-Gal4 antibodies were also not inf luenced by contact inhibition, although there was a small, ∼2-fold reduction in serum-deprived cells ( Figure 1B) . However, this small reduction is not sufficient to account for the strong repression of RSL1-inducible gene expression in serum-deprived 3T3 cells. These data suggest that attenuation of RSL1-induced gene expression by cell cycle arrest is not caused by changes in the levels of RheoSwitch components.
RSL1 is a non-steroidal inducer, and could conceivably be hindered from entering the cells under conditions of contact inhibition and serum deprivation. To determine whether this is the case, we used PonasteroneA, a steroid that can induce expression in the RheoSwitch system, albeit at considerably reduced efficiency compared with RSL1 (6). Using 3T3-Pip92 clone#11 that exhibited the strongest induction of gene expression in response to RSL1, we found that PonasteroneA also induced Pip92 expression in sparsely growing cells, but not in contact-inhibited dense cells. Furthermore, the induction of Pip92 expression in non-contactinhibited cells was strongly reduced when the cells were serum-deprived ( Figure 2C ). These data indicate that the cell cycle arrest-dependent reduction in inducible gene expression is not limited to a particular class of ligand and is unlikely to be caused by changes in intracellular ligand availability.
To determine whether loss of R heoSwitch ligand-induced gene expression in cell cycle-arrested cells is a universal phenomenon, we also investigated other cell types. We found that the mammary epithelial cell line NMuMG undergoes contact inhibition at high cell density and is growth-arrested by serum deprivation (Figure 3, A and B) . We therefore engineered these cells to express Pip92 under the control of the RheoSwitch system. Three independent clones were then analyzed for inducible Pip92 expression under sparse, contactinhibited and serum-deprived conditions. In contrast to NIH3T3 cells, induction of Pip92 in NMuMG cells was not affected by either contact inhibition or serum deprivation ( Figure 3C ). These findings were also substantiated using luciferase reporter assays ( Figure 3D ). These data therefore indicate that cell cycle arrest-dependent loss of inducibility in the RheoSwitch system is cell context-dependent.
Our experiments demonstrate that the RheoSwitch inducible expression system can be inf luenced by certain physiological conditions. Specifically, Remove autofluorescence from images of skin and other tissues to reveal the signals that you need to see. The dramatic improvement in signal-to-noise can increase sensitivity up to several hundredfold, enabling much smaller or fainter signals from biological targets to be detected earlier and accurately measured.
Call us at 1-800-383-7924 or go to www.cri-inc.com/maestro to learn more.
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Short Technical Reports cell cycle quiescence induced either by contact inhibition or by serum deprivation can substantially reduce the gene expression that can be achieved. This reduction is cell type-dependent, as we observed these effects in 3T3 cells but not in NMuMG cells. Induction is only reduced in 3T3 cells and not completely abrogated, as we observed substantial induction of luciferase activity in contact-inhibited 3T3 cells treated with RSL1 ligand compared with nontreated contact-inhibited 3T3 cells (Figure 2A) . The reason for this reduced cell contextdependent reduction in inducibility remains to be determined, but it does not appear to involve quiescence-regulated expression of RheoSwitch components, and it is common to both steroidal and non-steroidal inducers.
Our findings may limit the utility of the RheoSwitch system to answering certain basic research questions in which cells in the quiescent state need to be compared with normally cycling cells. In cells where cell cycle arrest affects the inducibility of the RheoSwitch system, it may nevertheless still be possible to achieve acceptable levels of induction if the proteins have long half-lives under conditions of quiescence and contact inhibition. This notion is supported by the observation that the effects of contact inhibition on Pip92 expression were more pronounced than in the luciferase activity assays (Figures 1C and  2A) . The short half-life of Pip92 (15 min) compared with that of firefly luciferase (2 h) is likely to contribute these differences.
Our data may also have implications for the application of RheoSwitch-like inducible gene expression systems in the context of gene therapy. The vast majority of somatic cells in vivo are in a quiescent state (10) and are therefore dependent on the type of cell being targeted, so high levels of induction may not be achievable in vivo. Furthermore, some types of cells in vivo may give a heterogeneous response to induction depending on their cell cycle status. These observations need to be taken into consideration during the further development of RheoSwitchlike inducible gene expression systems for the purposes of basic research and gene therapy.
